Back to Directory
Elarna Bio
East of England
AI-guided RNA therapies for chronic metabolic diseases
Elarna Bio is a biotechnology company developing long-acting RNA therapeutics for chronic metabolic diseases. It combines AI-driven discovery with RNA engineering to improve the duration of therapeutic activity.
The platform focuses on challenges associated with liver-targeted RNA treatments and is intended for applications ranging from rare genetic diseases to more common metabolic disorders. Specific drug candidates and clinical development programmes have not been publicly disclosed.